Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Exelixis
Exelixis
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Pediatric Brain Tumor Consortium
European Organisation for Research and Treatment of Cancer - EORTC
City of Hope Medical Center
University of Alabama at Birmingham
Day One Biopharmaceuticals, Inc.
Alaunos Therapeutics
BioMimetix JV, LLC
Massachusetts General Hospital
University of Oklahoma
Thomas Jefferson University
Bayer
BeiGene
Children's Oncology Group
National Cancer Institute (NCI)
Grupo Español de Investigación en Neurooncología
Washington University School of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiation Therapy Oncology Group
University of California, San Francisco
Istari Oncology, Inc.
Memorial Sloan Kettering Cancer Center
Candel Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
University of Nebraska
Sumitomo Pharma America, Inc.
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
TVAX Biomedical
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
The University of Texas Health Science Center at San Antonio
TVAX Biomedical
Rush University Medical Center
Children's Oncology Group
Karyopharm Therapeutics Inc
University of California, San Francisco
Indiana University
Weill Medical College of Cornell University
Burzynski Research Institute
National Cancer Institute (NCI)
Wake Forest University Health Sciences
City of Hope Medical Center
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
University of South Florida